As the flu season continues to rage, with the CDC reporting over 23,000 hospitalizations for influenza, several manufacturers have reported shortages of a medicine that can be used to counter it.
The American Society of Health-System Pharmacists (ASHP) reported a shortage of oseltamivir, otherwise known as Tamiflu, in several doses by five generic manufacturers. Amneal and Camber have reported a shortage in the 30 mg, 45 mg and 75 mg doses, while Macleods is reporting a shortage only in the 30 mg and 75 mg amounts. Teva and Zydus are listing a shortage of oral powder in the 60 mL bottle amount.
A reason for the shortages was not listed by the ASHP, but there are still doses available from other producers including Genentech, Ajanta, Alvogen and Strides Pharma. A hard date for when the supply will return to normal was not…
Click here to view original post
